Nivolumab (HER-2-neg gastric cancer, gastroesophageal junction cancer or oesophageal
adenocarcinoma): Injection concentrate for I.V. infusion 40 mg in 4 mL, Injection
concentrate for I.V. infusion 100 mg in 10 mL; Opdivo®
Page last updated: 1 July 2022